Neurotrophic Factors in the Peripheral Nervous System

Peripheral Neuropathy

Volumn 1, Issue , 2005, Pages 377-386

  Windebank, Anthony J ^a   McDonald, Elizabeth S ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343927974     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50020-X     Document Type: Chapter

References (94)

1. Aloe L. Intracerebral pretreatment with nerve growth factor prevents irreversible brain lesions in neonatal rats injected with ibotenic acid. Biotechnology 1987, 5:1085.
2. Aloyz R.S., Bamji S.X., Pozniak C.D., et al. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell Biol. 1998, 143:1691.
3. Apfel S.C. Is the therapeutic application of neurotrophic factors dead? Ann. Neurol. 2002, 51:8.
4. Arch R.H., Gedrich R.W., Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs)- a family of adapter proteins that regulates life and death. Genes Dev. 1998, 12:2821.
5. LNTR reduces NGF binding to TrkA on PC12 cells. Neuron. 1994, 13:203.
6. Barrett G.L., Bartlett P.F. The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:6501.
7. Berkowitz L.A., Riabowol K.T., Gilman M.Z. Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter. Mol. Cell. Biol. 1989, 9:4272.
8. Boniece I.R., Wagner J.A. Growth factors protect PC12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesis. J. Neurosci. 1993, 13:4220.
9. Bonni A., Brunet A., West A.E., et al. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286:1358.
10. Brodski C., Schnurch H., Dechant G. Neurotrophin-3 promotes the cholinergic differentiation of sympathetic neurons. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9683.
11. Brunet A., Bonni A., Zigmond M.J., et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 1999, 96:857.
12. Burdman J.A., Goldstein M.N. Synthesis and storage of a nerve growth protein in mouse submandibular glands. J. Exp. Zool. 1965, 160:183.
13. Butte M.J. Neurotrophic factor structures reveal clues to evolution, binding, specificity, and receptor activation. Cell. Mol. Life Sci. 2001, 58:1003.
14. Cardone M.H., Roy N., Stennicke H.R., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998, 282:1318.
15. Chan J.R., Cosgaya J.M., Wu Y.J., Shooter E.M. Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14661.
16. Chao M.V., Bothwell M. To cleave or not to cleave. Neuron. 2001, 33:9-12.
17. Chattopadhyay M., Wolfe D., Huang S., et al. In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3. Ann. Neurol. 2002, 51:19.
18. Cheng H.L., Steinway M., Delaney C.L., et al. IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol. Cell. Endocrinol. 2000, 170:211.
19. Corbit K.C., Foster D.A., Rosner M.R. Protein kinase C8 mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells. Mol. Cell. Biol. 1999, 19:4209.
20. Cowan W.M. Viktor Hamburger and Rita Levi-Montalcini: the path to the discovery of nerve growth factor. Annu. Rev. Neurosci. 2001, 24:551.
21. Datta S.R., Dudek H., Tao X., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231.
22. Deckwerth T.L., Elliott J.L., Knudson C.M., et al. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 1996, 17:401.
23. del Peso L., Gonzalez-Garcia M., Page C., et al. InterleGBRin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997, 278:687.
24. Demarchi F., Verardo R., Varnum B., et al. Gas6 anti-apoptotic signaling requires NF-kappa B activation. J. Biol. Chem. 2001, 276:31738.
25. Dobrowsky R.T., Jenkins G.M., Hannun Y.A. Neurotrophins induce sphingomyelin hydrolysis: modulation by co-expression of p75NTR with Trk receptors. J. Biol. Chem. 1995, 270:22135.
26. Enomoto H., Araki T., Jackman A., et al. GFR a1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 1998, 21:317.
27. Ernfors P. Local and target-derived actions of neurotrophins during peripheral nervous system development. Cell. Mol. Life Sci. 2001, 58:1036.
28. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342.
29. Fischer S.J., McDonald E.S., Gross L., Windebank A.J. Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo. Neurobiol. Dis. 2001, 8:1027.
30. Fischer S.J., Podratz J.L., Windebank A.J. Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia. Neurosci. Lett. 2001, 308:1.
31. Gill J.S., Windebank A.J. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J. Clin. Invest. 1998, 101:2842.
32. Greene S.H., Rydel R.E., Connolly J.L., Greene L.A. PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor. J. Cell Biol. 1986, 102:830.
33. Hamanoue M., Middleton G., Wyatt S., et al. p75-mediated NF-kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor. Mol. Cell. Neurosci. 1999, 14:28.
34. Hamburger V., Keefe E.L. The effects of peripheral factors on the proliferation and differentiation in the spinal cord of chick embryos. J. Exp. Zool. 1944, 96:223.
35. Honma H., Gross L., Windebank A.J. Hypoxia-induced apoptosis of dorsal root ganglion neurons is associated with DNA damage recognition and cell cycle disruption. Neurosci. Lett. 2004, 354:95.
36. Honma H., Podratz J.L., Windebank A.J. Acute glucose deprivation leads to apoptosis in a cell model of acute diabetic neuropathy. J. Peripher. Nerv. Syst. 2003, 8:65.
37. Howe C.L., Valletta J.S., Rusnak A.S., Mobley W.C. NGF signaling from clathrin-coated vesicles: evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway. Neuron 2001, 32:801.
38. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24:677.
39. Johnson J.E. Neurotrophic factors. Fundamental Neuroscience 1999, 611. Academic Press, Sa Diego. M.J. Zigmund, R.E. Bloom, S.C. Landis (Eds.).
40. Kane L.P., Shapiro V.S., Stokoe D., Weiss A. Induction of NF-kB by the Akt/PKB kinase. Curr. Biol. 1999, 9:601.
41. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 2000, 10:381.
42. Kennedy S.G., Kandel E.S., Cross T.K., Hay N. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 1999, 19:5800.
43. Kermer P., Klöcker N., Labes M., Böhr M. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo. J. Neurosci. 2000, 20:722.
44. Khursigara G., Orlinick J.R., Chao M.V. Association of the p75 neurotrophin receptor with TRAF6. J. Biol. Chem. 1999, 274:2597.
45. Korsching S. The neurotrophic factor concept: a reexamination. J. Neurosci. 1993, 13:2739.
46. Le-Niculescu H., Bonfoco E., Kasuya Y, et al. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 1999, 19:751.
47. Lee F.S., Chao M.V. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3555.
48. Lee F.S., Kim A.H., Khursigara G., Chao M.V. The uniqueness of being a neurotrophin receptor. Curr. Opin. Neurobiol. 2001, 11:281.
49. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 2001, 294:1945.
50. Lesser S.S., Lo D.C. CNTF II, I presume?. Nat. Neurosci. 2000, 3:851.
51. Levi-Montalcini R. The nerve growth factor thirty-five years later. In Vitro Cell. Dev. Biol. 1987, 23:227.
52. Levi-Montalcini R., Skaper S.D., Dal Toso R., et al. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 1996, 19:514.
53. Matsuzaki H., Tamatani M., Mitsuda N., et al. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J. Neurochem. 1999, 73:2037.
54. McCormick F. Activators and effectors of ras p21 proteins. Curr. Opin. Genet. Dev. 1994, 4:71.
55. McDonald E.S., Windebank A.J. Cisplatin-induced apoptosis of DRG neurons involves Bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol. Dis. 2002, 9:220.
56. Miller F.D., Kaplan D.R. Neurotrophin signalling pathways regulating neuronal apoptosis. Cell. Mol. Life Sci. 2001, 58:1045.
57. Miller F.D., Kaplan D.R. On Trk for retrograde signaling. Neuron 2001, 32:767.
58. Mitchell J.D., Wokke J.H., Borasio G.D. Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst. Rev. 2002, 3:CD002064.
59. Moore M.W., Klein R.D., Farinas I., et al. Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996, 382:76.
60. Muller G., Storz P., Bourteele S., et al. Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. EMBO J. 1998, 17:732.
61. Muller M., Wilder S., Bannasch D., et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med. 1998, 188:2033.
62. Nakagawara A. Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett. 2001, 169:107.
63. Nawa H., Takei N. BDNF as an anterophin: a novel neurotrophic relationship between brain neurons. Trends Neurosci. 2001, 24:683.
64. Neet K.E., Campenot R.B. Receptor binding, inter-nalization, and retrograde transport of neurotrophic factors. Cell. Mol. Life Sci. 2001, 58:1021.
65. Ochs G., Penn R.D., York M., et al. A Phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000, 1:201.
66. Ozes O.N., Mayo L.D., Gustin J.A., et al. NF-kB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401:82.
67. Patapoutian A., Reichardt L.F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 2001, 11:272.
68. Pichel J.G., Shen L., Sheng H.Z., et al. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996, 382:73.
69. Rena G., Guo S., Cichy S.C., et al. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 1999, 274:17179.
70. Riccio A., Pierchala B.A., Ciarallo C.L., Ginty D.D. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science 1997, 277:1097.
71. Romashkova J.A., Makarov S.S. NF-kB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401:86.
72. Sabatini P., McCormick F. Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. J. Biol. Chem. 1999, 274:24263.
73. Sanchez M.P., Silos-Santiago I., Frisen J., et al. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 1996, 382:70.
74. Sanchez-Perez I., Martinez-Gomariz M., Williams D., et al. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. Oncogene 2000, 19:5142.
75. Sanchez-Perez I., Murguia J.R., Perona R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 1998, 16:533.
76. Schuchardt A., DAgati V., Larsson-Blomberg L., et al. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994, 367:380.
77. Shimoke K, Chiba H. Nerve growth factor prevents 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease. J. Neurosci. Res. 2001, 63:402.
78. Shooter E.M. Early days of the nerve growth factor proteins. Annu. Rev. Neurosci. 2001, 24:601.
79. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217.
80. Sutter A., Riopelle R.J., Harris-Warrick R.M., Shooter E.M. Nerve growth factor receptors: characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells. J. Biol. Chem. 1979, 254:5972.
81. Tang Y., Zhou H., Chen A., et al. The Akt proto-oncogene links ras to pak and cell survival signals. J. Biol. Chem. 2000, 275:9106.
82. The BDNF Study Group (Phase III) A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999, 52:1427.
83. Vetter M.L., Martin-Zanca D., Parada L.F., et al. Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase C-g1 by a kinase activity associated with the product of the trk protooncogene. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:5650.
84. Vogel K.S., Parada L.F. Sympathetic neuron survival and proliferation are prolonged by loss of p53 and neurofibromin. Mol. Cell. Neurosci. 1998, 11:19.
85. Wada K., Okada N., Yamamura T., Koizumi S. Nerve growth factor induces resistance of PC12 cells to nitric oxide cytotoxicity. Neurochem. Int. 1996, 29:461.
86. Wellmer A., Misra V.P., Sharief M.K., et al. A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy. J. Peripher. Nerv. Syst. 2001, 6:204.
87. Wiesmann C., de Vos A.M. Nerve growth factor: structure and function. Cell. Mol. Life Sci. 2001, 58:748.
88. Wiesmann C., Ultsch M.H., Bass S.H., de Vos A.M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 1999, 401:184.
89. Yamada K., Mizuno M., Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 2002, 70:735.
90. Yamaguchi A., Tamatani M., Matsuzaki H., et al. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 2001, 276:5256.
91. Yang C.H., Murti A., Pfeffer S.R., et al. Interferon α/β promotes cell survival by activating nuclear factor kB through phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 2001, 276:13756.
92. Yuen E.C. The role of neurotrophic factors in disorders of peripheral nerves and motor neurons. Phys. Med. Rehabil. Clin. N. Am. 2001, 12:293.
93. Zhou H., Summers S.A., Birnbaum M.J., Pittman R.N. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J. Biol. Chem. 1998, 273:16568.
94. Zundel W., Swiersz L.M., Giaccia A. Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol. Cell. Biol. 2000, 20:1507.